Carlson Capital’s Evolent Health EVH Stock Holding History

Carlson Capital’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-450,600	Closed	-$8.79M	–	320
2015 Q2	$8.79M	Buy	+450,600	New	+$8.4M	0.1%	222

Other funds holding EVH

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Carlson Capital's EVH Position: Q3 2015 in Review

Carlson Capital sold out of Evolent Health (EVH) in Q3 2015, closing a stake of 450,600 shares — an estimated $8.79M sold.

Carlson Capital first reported a position in EVH in Q2 2015 and held it in 1 quarter. The position peaked at $8.79M in Q2 2015. 69 funds tracked by Wall St. Rank hold EVH as of Q3 2015.

Carlson Capital reported no remaining Evolent Health position as of Q3 2015 after selling out during the quarter.
Carlson Capital sold 450,600 Evolent Health shares in Q3 2015, an estimated $8.79M.
Carlson Capital first reported a position in Evolent Health in Q2 2015 and held it in 1 quarter.
Carlson Capital's Evolent Health position peaked at $8.79M in Q2 2015.
69 funds tracked by Wall St. Rank held Evolent Health as of Q3 2015.

Based on Carlson Capital's 13F filing for Q3 2015, filed 16 Nov 2015.